These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39412908)

  • 1. Comparison of magnetic seed and RFID methods in the localization of non-palpable breast lesions.
    Sanli AN; Tekcan Sanli DE; Golshan M; Sezgin E; Celik V; Aydogan F
    J Cancer Res Ther; 2024 Jul; 20(5):1435-1439. PubMed ID: 39412908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency as a method of localizing impalpable breast lesions.
    Malik M; Brookes P; Kasana MI; Tromans L; Audrey Chew WY; Green MJ
    Surgeon; 2024 Oct; 22(5):296-300. PubMed ID: 39179450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers.
    Lee MK; Sanaiha Y; Kusske AM; Thompson CK; Attai DJ; Baker JL; Fischer CP; DiNome ML
    Breast Cancer Res Treat; 2020 Jul; 182(2):299-303. PubMed ID: 32451679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LOCalizer Radiofrequency Identification System: An Effective New Technology for Localizing Non-Palpable Breast Lesions for Surgery.
    Cullinane CM; Byrne J; Akmenkalne L; O' Leary DP; Connors AM; Corrigan MA; Redmond HP; Kelly L; O' Sullivan MJ
    Surg Innov; 2021 Aug; 28(4):473-478. PubMed ID: 33085567
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
    den Dekker BM; Christenhusz A; van Dalen T; Jongen LM; van der Schaaf MC; Dassen AE; Pijnappel RM
    BMC Cancer; 2022 Mar; 22(1):305. PubMed ID: 35317766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
    Veyssiere H; Dressaire M; Pete R; Pinard C; Molnar I; Abrial C; Ginzac A; Durando X; Tekath M
    BMC Cancer; 2023 Jul; 23(1):679. PubMed ID: 37468859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
    Micha AE; Sinnett V; Downey K; Allen S; Bishop B; Hector LR; Patrick EP; Edmonds R; Barry PA; Krupa KDC; Rusby JE
    Breast Cancer; 2021 Jan; 28(1):196-205. PubMed ID: 32974810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.
    Malter W; Holtschmidt J; Thangarajah F; Mallmann P; Krug B; Warm M; Eichler C
    In Vivo; 2019; 33(5):1559-1564. PubMed ID: 31471405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-frequency identification (RFID) tag localisation of non-palpable breast lesions a single centre experience.
    Almalki H; Rankin AC; Juette A; Youssef MG
    Breast; 2023 Jun; 69():417-421. PubMed ID: 37141675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.
    Powell M; Gate T; Kalake O; Ranjith C; Pennick MO
    Breast J; 2021 Jun; 27(6):529-536. PubMed ID: 33855763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience of magnetic seed localization for impalpable breast lesion excision: First 100 cases performed in a single Irish tertiary referral centre.
    Murphy E; Quinn E; Stokes M; Kell M; Barry M; Flanagan F; Walsh SM
    Surgeon; 2022 Jun; 20(3):e36-e42. PubMed ID: 33840595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
    Zacharioudakis K; Down S; Bholah Z; Lee S; Khan T; Maxwell AJ; Howe M; Harvey J
    Eur J Surg Oncol; 2019 Nov; 45(11):2016-2021. PubMed ID: 31288944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
    Aydogan T; Sezgin E; Ilvan S; Yilmaz OC; Aslan N; Golshan M; Aydogan F
    Clin Breast Cancer; 2020 Feb; 20(1):e9-e13. PubMed ID: 31699672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
    Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
    Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions.
    McGugin C; Spivey T; Coopey S; Smith B; Kelly B; Gadd M; Hughes K; Dontchos B; Specht M
    Breast Cancer Res Treat; 2019 Oct; 177(3):735-739. PubMed ID: 31302856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer.
    Wazir U; Tayeh S; Perry N; Michell M; Malhotra A; Mokbel K
    In Vivo; 2020; 34(1):233-238. PubMed ID: 31882483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study.
    D'Angelo A; Scardina L; Palma S; Cicero SL; Maresca A; Caprini F; Biondi E; Franco A; Terribile D; Franceschini G; Belli P; Manfredi R
    Eur Radiol; 2024 Jan; 34(1):149-154. PubMed ID: 37526666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAVI Scout® System for Excision of Non-Palpable Breast Lesions.
    Farha MJ; Simons J; Kfouri J; Townsend-Day M
    Am Surg; 2023 Jun; 89(6):2434-2438. PubMed ID: 35509218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of wire-guided localization (WGL) and radio-guided occult lesion localization (ROLL) in localization of non-palpable breast lesions.
    Elzohery YH; Gomaa MM; Mohamed G; Fadlalla WM; Taha SN; Ibraheem MH
    World J Surg Oncol; 2023 Aug; 21(1):266. PubMed ID: 37626332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience of the Magseed
    Crèvecoeur J; Jossa V; Di Bella J; Coibion M; Crèvecoeur A
    Gland Surg; 2023 May; 12(5):566-576. PubMed ID: 37284712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.